Commonest auto-immune cause of polyarthritis
Presentation: 50F with poly-PIPJ arthralgia
Diagnosis- clinical: ANA sensitive and antiCCP specific
Management: 1. Prednisolone, 2. Methrotrexate
Felty syndrome: rheumatoid arthitis + splenomegaly + neutropenia [V common MCQ!!]
Associated with:
Increase in cardiovascular deaths- biggest source of increased mortality (x2)
ILD (Interstitial Lung Disease): lower lobe distribution and Bronchiectasis
History:
50F with polyarthritis
Poor response to NSAIDs
Examination:
PIPJ & MTPJ swelling
Swan neck deformity- late sign
Maculopapular rash
Investigations
Rheumatoid Factor: 70% 50%
anti-CCP: 75% 95%
ANA: 90% 20%
CRP/ ESR 80% 20%
XR joints
Diagnostic criteria: clinical
Differentials:
Sero +ve arthritis: Systemic Lupus Erythematous , Systemic Sclerosis, Sjogren's Syndrome
Sero -ve arthritis (PEAR): psoriatic, enteritis, ankylosing spondylitis, reactive arthritis
Prednisolone
Methotrexate
Sulfasalazine
Etanercept (TNF antagonist)
Screen for Tuberculosis and HBV & HCV prior to starting etanercept.
Referral to Rheumatology
Rheumatoid arthritis outcomes are better with early aggressive interventions to prevent join destruction. Therefore suspicions of rheumatoid arthritis should result in prompt referral to Rheumatology, to start treatment before irreversible joint destruction occurs.
Cardiovascular disease
Increase rates of:
Congestive heart failure- particularly HFpEF (diasytolic)
https://www.nhs.uk/conditions/rheumatoid-arthritis/diagnosis/
Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013 Oct;166(4):622-628.e1. doi: 10.1016/j.ahj.2013.07.010. Epub 2013 Aug 29. PMID: 24093840; PMCID: PMC3890244.
Page written in 2024.